NOTE REPURCHASE AGREEMENTNote Repurchase Agreement • July 24th, 2008 • Vaxgen Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 24th, 2008 Company Industry JurisdictionTHIS NOTE REPURCHASE AGREEMENT (this “Agreement”) to repurchase VaxGen, Inc. 51/2% Convertible Senior Subordinated Notes Due April 1, 2010 is made as of July 22, 2008, by and between Deutsche Bank AG London (“Holder”), on the one hand, and VaxGen, Inc., a Delaware corporation (“Company”), on the other hand.
NOTE REPURCHASE AGREEMENTNote Repurchase Agreement • July 24th, 2008 • Vaxgen Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 24th, 2008 Company Industry JurisdictionTHIS NOTE REPURCHASE AGREEMENT (this “Agreement”) to repurchase VaxGen, Inc. 51/2% Convertible Senior Subordinated Notes Due April 1, 2010 is made as of July 22, 2008, by and between Quintessence Fund L.P., a Cayman limited partnership (“Holder”), on the one hand, and VaxGen, Inc., a Delaware corporation (“Company”), on the other hand.
NOTE REPURCHASE AGREEMENTNote Repurchase Agreement • July 24th, 2008 • Vaxgen Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 24th, 2008 Company Industry JurisdictionTHIS NOTE REPURCHASE AGREEMENT (this “Agreement”) to repurchase VaxGen, Inc. 51/2% Convertible Senior Subordinated Notes Due April 1, 2010 is made as of July 22, 2008, by and between QVT Fund LP, a Cayman limited partnership (“Holder”), on the one hand, and VaxGen, Inc., a Delaware corporation (“Company”), on the other hand.